SCHEMBL11233748

SCHEMBL11233748

CCN(C(=O)c1cccc(C)c1)c1ccc([Ge]OOO)cc1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.50
TDP1 Q9NUW8 1/20 0.50
HDAC8 Q9BY41 1/20 0.43
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
TSHR P16473 1/20 0.42
ALDH1A1 P00352 4/20 0.41
HTT P42858 2/20 0.40
TP53 P04637 3/20 0.40
PARP1 P09874 1/20 0.39
LMNA P02545 2/20 0.39
MAPT P10636 2/20 0.39
MAPK14 Q16539 1/20 0.39
ADAMTS4 O75173 1/20 0.39
NPC1 O15118 2/20 0.38
RAB9A P51151 1/20 0.38
RAD52 P43351 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11235371 0.89 ALDH1A1 (0.47) HPGDTDP1MEN1KMT2AALDH1A1
SCHEMBL11233109 0.84 HSD17B2 (0.48) HPGDTDP1TP53PARP1
SCHEMBL18773872 0.79 HPGD (0.64) HPGDTDP1HDAC8MEN1KMT2A
Water SCHEMBL11233729 0.77 HPGD (0.57) HPGDTDP1HDAC8MEN1KMT2A
Water SCHEMBL11233763 0.77 HPGD (0.57) HPGDTDP1HDAC8MEN1KMT2A
SCHEMBL11251117 0.74 SENP1 (0.48) TSHRALDH1A1TP53LMNAMAPT
SCHEMBL11227688 0.72 SMN1; SMN2 (0.52) TSHRALDH1A1HTTTP53LMNA
SCHEMBL11230427 0.72 GFER (0.43) HPGDKMT2ATSHRALDH1A1HTT
SCHEMBL3456171 0.71 TSHR (0.75) HPGDTDP1MEN1KMT2ATSHR
SCHEMBL11238514 0.70 MLYCD (0.34) TDP1MEN1KMT2ATSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4361579-A TREATMENT OF IMMUNE DISEASES WITH ORGANOGERMANIUM POLYMERS YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1982-11-30 US disclosed
EP-0025965-A2 Organogermanium compounds, a method for producing them and pharmaceutical compositions comprising them Yoshitomi Pharmaceutical Industries, Ltd. (JP) 1981-04-01 EP disclosed